Autolus Therapeutics PLC (NAS:AUTL) Stock News, Headlines & Updates
Autolus Therapeutics PLC Stock News from GuruFocus
- 1
Jul 24, 2025
Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
Marketwired • 7:00am
Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 | AUTL Stock News
GuruFocus News • 6:46am
Jul 21, 2025
Analyst Reiterates Buy Rating on Autolus Therapeutics (AUTL) | AUTL Stock News
GuruFocus News • 9:32am
Autolus Therapeutics' CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acut
GuruFocus News • 6:18am
Autolus Therapeutics (AUTL) Gains EC Approval for AUCATZYL in Leukemia Treatment | AUTL Stock News
GuruFocus News • 6:18am
Jul 15, 2025
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | AUTL Stock News
GuruFocus News • 3:19pm
Jun 24, 2025
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
PRNewswire • 12:00pm
Jun 12, 2025
Needham Reiterates Buy Rating for Autolus Therapeutics (AUTL) at $10.00 | AUTL Stock News
GuruFocus News • 11:30am
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
GuruFocus News • 1:15am
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
Marketwired • 1:00am
May 29, 2025
Autolus Therapeutics to Participate in Upcoming Investor Conferences
Marketwired • 4:00pm
Autolus Therapeutics to Participate in Upcoming Investor Conferences | AUTL Stock News
GuruFocus News • 3:18pm
May 23, 2025
Autolus Therapeutics (AUTL) Secures EMA Panel Endorsement for Leukemia Therapy
GuruFocus News • 9:57am
Autolus Therapeutics (AUTL) Secures Key EU Panel Recommendation for Obe-cel | AUTL Stock News
GuruFocus News • 7:46am
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-
GuruFocus News • 7:45am
May 14, 2025
Autolus Therapeutics (AUTL) Unveils Promising Findings at EHA Congress | AUTL Stock News
GuruFocus News • 9:01am
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
Marketwired • 9:00am
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress | AUTL Stock News
GuruFocus News • 8:47am
Syncona Portfolio Ltd Expands Stake in Autolus Therapeutics PLC
GuruFocus News • 7:31pm
May 09, 2025
Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion Plans
GuruFocus News • 1:20am
Q1 2025 Autolus Therapeutics PLC Earnings Call Transcript
GuruFocus News • 11:16pm
May 08, 2025
Autolus Therapeutics PLC Q1 2025 Earnings: EPS Matches Estimates at $(0.26), Revenue Surges to $9.0 Million, Beating Expectations
GuruFocus News • 7:32am
AUTL Exceeds Revenue Expectations with Strong Q1 Performance | AUTL Stock News
GuruFocus News • 6:48am
Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
Marketwired • 6:00am
May 07, 2025
Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect
GuruFocus News • 9:09am
Apr 25, 2025
Autolus Therapeutics (AUTL) Gains UK Approval for AUCATZYL in Leukemia Treatment | AUTL Stock News
GuruFocus News • 11:46am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news